Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 5, 1998, Pages 473-476

  Zimmerman, Dennis M ^a   Cantrell, Buddy E ^a   Smith, Edward C R ^a   Nixon, James A ^a   Bruns, Robert F ^a   Gitter, Bruce ^a   Hipskind, Philip A ^a   Ornstein, Paul L ^a   Zarrinmayeh, Hamideh ^a   Britton, Thomas C ^a   Schober, Douglas A ^a   Gehlert, Donald R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLBENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; NEUROPEPTIDE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG SYNTHESIS; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

BENZIMIDAZOLES; CELL LINE; RECEPTORS, NEUROPEPTIDE Y; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032478050     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00048-1     Document Type: Article

References (15)

1. 1. Allen, Y. S.; Adrian, T. E.; Allen, J. M.; Tatemoto, K.; Crow, T. J.; Bloom, S. R.; Polak, J. M. Science 1983, 221, 877.
2. 2. Wahlestedt, C.; Reis, D. J. Annu. Rev. Pharmacol. Toxicol. 1993, 32, 309.
3. 3. Blomqvist, A. G.; Herzog, H. Trends Pharmacol Sci. 1997, 20, 294.
4. 4. Walker, P.; Grouzmann, E.; Burnier, M.; Waeber, B. Trends Pharmacol Sci 1991, 12, 111.
5. 5. Clark, J. T.; Kalra, P. S.; Crowley, W. R.; Kalra, S. P. Endocrinology 1984, 115, 427.
6. 6. Stanley, B. G.; Kyrkouli, S. E.; Lampert, S.; Leibowitz, S. F. Peptides 1986, 7, 1189.
7. 7. Rudolf, K.; Eberlein, W.; Wieland, H. A.; Willim, K. D.; Entzeroth, M.; Wienen, W.; Beck-Sickinger, A. G.; Doods, H. N. Eur. J. Pharmacol. 1994, 271, R11.
8. 8. Serradeil-Le Gal, C.; Valeet, G.; Rouby, P. E.; Pellet, A.; Oury-Donat, F.; Brossard, G.; Lespy, L.; Marty, E.; Neliat, G.; de Cointet, P.; Maffrand, J. P.; LeFur, G. FEBS Lett. 1995, 362, 192.
9. 9. Wright, J.; Bolton, G.; Creswell, M.; Downing, D.; Georgic, L.; Heffner, T.; Hodges, J.; MacKenzie, R.; Wise, L. Bioorg. Med. Chem. Lett. 1996, 6, 1809.
10. 10. Hipskind, P. A.; Lobb, K. L.; Nixon, J. A.; Britton, T. C.; Bruns, R. F.; Catlow, J.; Dieckman-McGinty, D. K.; Gackenheimer, S. L.; Gitter, B. D.; Iyengar, S.; Schober, D. A.; Simmons, R. M. A.; Swanson, S.; Zarrinmayeh, H.; Zimmerman, D. M.; Gehlert, D. R. J. Med. Chem. 1997, 40, 3712.
11. 11. Zarrinmayeh, H.; Nunes, A. M.; Ornstein, P. L.; Zimmerman, D. M.; Arnold, M. B.; Schober, D. A.; Gackenheimer, S. L.; Bruns, R. F.; Hipskind, P. A.; Britton, T. C.; Cantrell, B. E.; Gehlert, D. A. J. Med. Chem. In press.
12. 12. Friedhelm, F.; Rascher, W.; Michael, M. C. Naunyn-Schmied. Arch. Pharmacol. 1991, 344, 1.
13. 13. Alvarez, R. A. and Daniels, D. V. Anal. Biochem. 1990, 187, 98.
14. 14. Gordon, E. A.; Kohout, T. A. and Fishman, P. H. J. Neurochem. 1990, 55, 506.
15. 15. Beck-Sickinger, A. G.; Jung, G. Biopolymers (Peptide Science), 1995, 37, 123